Buy STELARA 45 MG USTEKINUMAB

Stelara 45 mg is a subcutaneous solution used for managing moderate to severe plaque psoriasis. This biologic medication helps reduce inflammation and improve skin condition.

Strength

45 MG

Pack Size

0.5ML

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Stelara 45 mg is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy. It may also be used for other inflammatory conditions as determined by a healthcare provider. Stelara works by targeting specific proteins in the immune system to reduce inflammation and improve symptoms.

Side Effects

Common effects of Stelara 45 mg may include redness, itching, or swelling at the injection site. Some individuals may experience headaches, fatigue, or upper respiratory infections. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

Stelara 45 mg should be used with caution in individuals with a history of infections or allergic reactions to ustekinumab. It is important to follow proper storage and handling instructions to maintain the medication's effectiveness. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

Stelara 45 mg may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how Stelara works, so it is advisable to discuss lifestyle factors with your healthcare provider.

References

Frequently Asked Questions

Stelara 45 mg is used for managing moderate to severe plaque psoriasis and other inflammatory conditions.

Stelara 45 mg is administered as a subcutaneous injection, typically at the healthcare provider's office or as directed.

Common side effects include redness, itching, or swelling at the injection site, headaches, fatigue, and upper respiratory infections.

Stelara 45 mg may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Stelara 45 mg should be stored in the refrigerator between 2°C to 8°C (36°F to 46°F) and protected from light.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.